Temple gene editing spinout ExpressCells quietly ceases operations, sued by lender
ExpressCells' former CEO said the company suffered after three of its customers went out of business and several others instituted cost-cutting measures. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 15, 2024 Category: Pharmaceuticals Authors: John George Source Type: news

Viewpoint: Time for the state to focus on the real issue facing families
Hint: It's not IVF. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 15, 2024 Category: Pharmaceuticals Authors: Marie Leech Source Type: news

Osmind CEO Lucia Huang talks mental health software, Y Combinator and surfing
Osmind is using software to eradicate psychiatrist's "pajama time." Investors have backed it to the tune of $57 million. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 15, 2024 Category: Pharmaceuticals Authors: Simon Campbell Source Type: news

Cost frustrations bubble over at healthcare hearing
Those who testified at Thursday's cost growth benchmark hearing were all passionate in their point that the price of health care is too high — though they had different opinions on who or what was to blame. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Sam Drysdale Source Type: news

New behavioral health hospital with 72 beds to open in McKinney
A large behavioral health hospital has debuted in McKinney, offering increased capacity to treat mental health concerns and substance abuse in Collin County and the rapidly growing North Texas region. Read on to see specifics about the new facility and what it adds to the broader DFW health care matrix. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Noor Adatia Source Type: news

Jennifer Doudna's Women In Enterprising Science incubator is giving young women scientists room to grow
The third cohort is going through the Women in Enterprising Science program, thanks to Jennifer Doudna's Innovative Genomics Institute at UC Berkeley and Horizon Ventures co-founder Solina Chau. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

How a daughter of refugees founded a biotech to combat diseases that have afflicted her family
Juvena Therapeutics CEO Hanadie Yousef has a compelling family narrative. It may have inspired her fight against chronic illnesses. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Startup to Watch: Accompany Health
The health care firm is hoping to redefine the way care is provided to low-income patients with complex needs. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Nate Doughty Source Type: news

Startup to Watch: Ounce Care
The D.C.-based startup operates at the junction of housing and health. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Nate Doughty Source Type: news

These are the next generation of biotech superstars in the Bay Area
We take a look at women in life sciences in the Bay Area who leading the next generation. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: William Hicks Source Type: news

Paid.care could soon help Tennessee employers offer this benefit to employees for free
The nation is in the grips of a home care worker shortage. Much of the care is now provided by loved ones. What many of them don't know is that they can get paid to give this care. That's where Paid.care comes in, and they want to work with employers to get the word out. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Nikki Ross Source Type: news

Trially wants to transform $22.6B clinical trial industry
Trially, a health tech startup in Kansas City, wants to modernize the clinical trial recruitment process with an artificial intelligence platform. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Grace Mayer Source Type: news

Women of Influence 2024: Lisa Murphy, Cambia Health Solutions
Lisa Murphy helps guide Cambia's efforts to make health coverage easier for more than 3 million members in the region. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Source Type: news

Women of Influence 2024: Tara Marshall, Providence Health Plan
As a regulatory and compliance manager with Providence Health Plan, Tara Marshall is dedicated to improving the experience of Providence members through empathy and professionalism. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Source Type: news

With $9.4M at end of Q4, vTv Therapeutics says it has enough cash to get through Phase 3 study
High Point ’s biopharmaceutical company says it has enough cash on hand to make it through two years of its Phase 3 study despite a decrease after almost being kicked off NASDAQ in 2023 due to poor financials. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Lillian Johnson Source Type: news